CTOs on the Move


 
Numoda is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.numoda.com
  • 601 Walnut St
    Philadelphia, PA USA 19106
  • Phone: 215.238.8881

Executives

Name Title Contact Details

Similar Companies

El Paso Health

To build relationships with our Members, Providers, and Partners that strengthen the delivery of healthcare in our community and promotes access to quality healthcare for children, families, and individuals.

NJMHI

NJMHI is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Booth Medical Equipment

Booth Medical Equipment is a Alexander, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Health

Advanced Health is a Orland Park, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.